Vivos Therapeutics VVOS
NASDAQ VVOS
$0.10 +0.00 (+2.24%)
At close: Nov 9, 2026 · 4:00 PM EST

Vivos Therapeutics (VVOS) Capital Expenditures (2020 - 2026)

Updated

Vivos Therapeutics (VVOS) recorded Capital Expenditures of $416,000 in Q2 2026, down 46.0% from $771,000 a year earlier.

Analysis

Vivos Therapeutics (VVOS) Capital Expenditures (2020 - 2026) Analysis & Trends

On a TTM basis, Vivos Therapeutics' Capital Expenditures came in at $7.07 million as of Jun 30, 2026, up 465.4% year-over-year; for FY2025, it came in at $7.53 million.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 128.8% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $568,000 in FY2024 (-33.4%), $853,000 in FY2023 (-7.7%), $924,000 in FY2022 (-61.4%) and $2.4 million in FY2021.
  • Quarterly Capital Expenditures has ranged from -$83,000 in Q3 2025 to $6.72 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in 1 of the last five quarters, with an average decline of 25.2%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 302.2% in Q4 2021, against a decline of 85.2% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $18,000 (Q1 2026), $6.72 million (Q4 2025) and -$83,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn 437.00 Mn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn 513.00 Mn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn 255.00 Mn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn 113.10 Mn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn 503.00 Mn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn 237.00 Mn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn 180.00 Mn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn 63.60 Mn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn 143.00 Mn
10 Vivos Therapeutics 1.68 Mn -7.36 Mn 2.95 Mn 416,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 416,000.00
Mar 31, 2026 18,000.00
Dec 31, 2025 6.72 Mn
Sep 30, 2025 -83,000.00
Jun 30, 2025 771,000.00
Mar 31, 2025 122,000.00
Dec 31, 2024 165,000.00
Sep 30, 2024 192,000.00
Jun 30, 2024 60,000.00
Mar 31, 2024 151,000.00
Dec 31, 2023 165,000.00
Sep 30, 2023 154,000.00
Jun 30, 2023 245,000.00
Mar 31, 2023 289,000.00
Dec 31, 2022 200,000.00
Sep 30, 2022 100,000.00
Jun 30, 2022 504,000.00
Mar 31, 2022 120,000.00
Dec 31, 2021 382,000.00
Sep 30, 2021 441,000.00
API Access

Vivos Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VVOS&period=max&api_key=YOUR_API_KEY